The MDMA-Neurotoxicity Controversy: Implications for Clinical Research with Novel Psychoactive Drugs

MDMA (3,4-methylenedioxymethamphetamine) can cause lasting damage to serotonin neurons in the brain, raising concerns about its safety for both recreational and therapeutic use. The authors review evidence from animal studies showing that MDMA produces dose-dependent serotonergic neurotoxicity, and they discuss the implications for humans who use the drug. They note that while some studies suggest potential therapeutic benefits for MDMA in psychotherapy, the neurotoxic risks must be carefully weighed. The paper emphasizes the need for further research to clarify the extent of neurotoxicity in humans and to establish safe guidelines for any medical applications.

Study at a glance

Abstract

GROB, CHARLES S. M.D.; BRAVO, GARY L. M.D.; WALSH, ROGER N. M.D., Ph.D.; LIESTER, MITCHELL B. M.D. Author Information